ELAB earnings: real EPS beat/miss history, P/E -0.00. Updated 2026-07-23.
PMGC Holdings (ELAB) Research Hub
PMGC Holdings (ELAB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 4.52 USD (-2.16%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.00, market cap 0.00B. This hub links to the full technical, earnings and options research available for ELAB.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.52 USD (-2.16%) |
| 52-week range | 4.52 USD – 15.1 USD |
| Trend regime | Range |
| 14-day RSI | 20.6 (Oversold) |
| Trailing P/E | -0.00 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for ELAB
Covered Call on ELAB: how it works, illustrative setup around the real 4.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ELAB: how it works, illustrative setup around the real 4.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ELAB: how it works, illustrative setup around the real 4.52 USD price, max profit/loss, breakeven and when to use it. Educational.
ELAB technical analysis: range, last 4.52 USD, RSI 20.6, 52w range 4.52 USD–15.1 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ELAB in?
PMGC Holdings (ELAB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ELAB in an uptrend or downtrend?
As of 2026-09-11, ELAB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ELAB's trailing P/E ratio?
ELAB's trailing P/E is -0.00, with a market cap of 0.00B. See the earnings research page for full valuation detail.